EUVIMEDEUVIMED entdecken
Crossref

An ever-stronger case for circulating tumor DNA monitoring in ALK+ lung cancer

Petros Christopoulos

AME Clinical Trials Review · 2023

DOI: 10.21037/actr-23-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AME Clinical Trials Review, 2023. Verfasst von Petros Christopoulos. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Christopoulos, P. (2023). An ever-stronger case for circulating tumor DNA monitoring in ALK+ lung cancer. AME Clinical Trials Review. https://doi.org/10.21037/actr-23-4

Vancouver

Christopoulos P. An ever-stronger case for circulating tumor DNA monitoring in ALK+ lung cancer. AME Clinical Trials Review. 2023. doi:10.21037/actr-23-4

BibTeX
@article{Christopoulos2023,
  author = {Christopoulos, Petros},
  title = {An ever-stronger case for circulating tumor DNA monitoring in ALK+ lung cancer},
  journal = {AME Clinical Trials Review},
  year = {2023},
  doi = {10.21037/actr-23-4}
}
Kostenlos starten →